The anti-inflammatory feature of glucagon-like peptide-1 and its based diabetes drugstherapeutic potential exploration in lung injury
Preclinical studies have suggested potential biomarkers such as circulating free IGF levels, mutations of p53, BRCA1, KRAS and BRAF, IRS2 copy number gain, InsR/IGF-IR overexpression, InsR/IGF-IR pathway activation, PTEN loss, CD24, mesenchymal markers, -catenin/TCF activity, FUS-DDIT3 fusion, and ERG [192,193,194,195,196,197,198,199,200,201]
Intern J Poult Sci 2011
I would recommend looking at this table for lipo cutoff values
She discovered that a hormone called GLP-1 (glucagon-like peptide-1) plays an important role in how our bodies respond to food